<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN"
       "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" dtd-version="1.3" article-type="research-article" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="nlm-ta">Ulutas Med J</journal-id>
   <journal-title-group>
    <journal-title>The Ulutas Medical Journal</journal-title>
    <abbrev-journal-title>Ulutas Med J</abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="ppub">2149-0430</issn>
   <issn pub-type="epub">2149-388X</issn>
   <publisher>
    <publisher-name>Hayriye Zehra Ulutaş</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.5455/umj.20230201114207</article-id>
   <article-id pub-id-type="publisher-id">142488</article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>Original Article</subject>
    </subj-group>
    <subj-group subj-group-type="subject">
     <subject>Cardiovascular Surgery</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title>Comparison of Midterm and Long-Term Effects of Cord Protection Methods on Left Ventricular Function in Mitral Valve Replacement Surgery</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8028-8993</contrib-id>
     <name name-style="western">
      <surname>Arslanoglu</surname>
      <given-names>Yavuz</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8761-2303</contrib-id>
     <name name-style="western">
      <surname>Deniz</surname>
      <given-names>Hayati</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff2">2</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0282-9114</contrib-id>
     <name name-style="western">
      <surname>Ustunsoy</surname>
      <given-names>Hasim</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff3">3</xref>
    </contrib>
    <aff id="aff1">
     <label>1</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/00pkvys92</institution-id>
      <institution>Dr. Ersin Arslan Education and Research Hospital, Department of Cardiovascular Surgery, Gaziantep, Turkey</institution>
     </institution-wrap>
    </aff>
    <aff id="aff2">
     <label>2</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/04nvpy675</institution-id>
      <institution>Department of Gaziantep İslam, Bilim ve Teknoloji University, Faculty of Medicine, Gaziantep, Turkey</institution>
     </institution-wrap>
    </aff>
    <aff id="aff3">
     <label>3</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/00pkvys92</institution-id>
      <institution>Anadolu Health Care Center, Department of Cardiovascular Surgery, Kocaeli, Turkey</institution>
     </institution-wrap>
    </aff>
   </contrib-group>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2023-03-09">
    <day>09</day>
    <month>03</month>
    <year>2023</year>
   </pub-date>
   <pub-date publication-format="print" date-type="collection">
    <year>2023</year>
   </pub-date>
   <volume>9</volume>
   <issue>1</issue>
   <fpage>35</fpage>
   <lpage>41</lpage>
   <history>
    <date date-type="received" iso-8601-date="2023-02-01">
     <day>01</day>
     <month>02</month>
     <year>2023</year>
    </date>
    <date date-type="rev-recd" iso-8601-date="2023-02-10">
     <day>10</day>
     <month>02</month>
     <year>2023</year>
    </date>
    <date date-type="accepted" iso-8601-date="2023-02-24">
     <day>24</day>
     <month>02</month>
     <year>2023</year>
    </date>
   </history>
   <permissions>
    <copyright-statement>© 2023 The Author(s)</copyright-statement>
    <copyright-year>2023</copyright-year>
    <license>
     <ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
     <license-p>This is an open access article distributed under the CC BY-NC 4.0 licence.</license-p>
    </license>
   </permissions>
   <self-uri xlink:href="https://www.ulutasmedicaljournal.com/?mno=142488"/>
   <self-uri content-type="pdf" xlink:href="https://www.ulutasmedicaljournal.com/pdf/142488.pdf"/>
   <abstract>
    <p>Introduction: Our study aimed to determine the effects of cord protection methods applied in Mitral valve replacement (MVR) surgery on left ventricular function. Materials and Methods: MVR surgery was performed on 634 patients using either single or combined procedures. Of these patients, 358 (56.5%) underwent conventional MVR surgery, 121 (19.1%) underwent total chordal protection, and 155 (24.4%) underwent posterior chordal preservation. All patients were evaluated as class 3 and 4 according to the New York functional classification (NYHA). Left ventricular diastolic end-diameter (SVDSD), left ventricular systolic end-diameter (SVSSD), end-diastolic volume (EDV), end-systolic volume (ESV), and ejection fraction (EF) were compared between groups. Results: The degree of valve insufficiency was 3 and 4 in patients with mitral insufficiency. The mortality risk for patients undergoing conventional surgical operations was 4.257 times higher (OR:4.25; 95%CI:1.22-14.76). The study showed positive effects of chordal protection on the clinical status and echocardiographic parameters of undergoing MVR surgery (p&lt;0.01). Conclusion: We believe cord protection methods positively affect left ventricular function after MVR. In particular, total chordal protection will positively affect left ventricular function.</p>
   </abstract>
   <kwd-group kwd-group-type="author">
    <kwd>Mitral valve replacement</kwd>
    <kwd>total chordal protection</kwd>
    <kwd>posterior chordal protection</kwd>
   </kwd-group>
   <funding-group>
    <funding-statement>Funding information was not reported in the published version of this article.</funding-statement>
   </funding-group>
  </article-meta>
 </front>
 <body>
  <sec id="sec-1">
   <title>Introduction</title>
   <p id="b-1">The ideal solution for treating valve diseases is to repair or replace the valve before symptoms appear and irreversible damage occurs in the myocardium (    <xref ref-type="bibr" rid="ref1">1</xref>
). Valve replacement is the first option in the surgical treatment of valve lesions where repair is impossible (    <xref ref-type="bibr" rid="ref2">2</xref>
,    <xref ref-type="bibr" rid="ref3">3</xref>
). Heart valve prostheses, which are used in cardiac surgery for over forty years, reduce symptoms and extend life in suitable patient groups (    <xref ref-type="bibr" rid="ref4">4</xref>
,    <xref ref-type="bibr" rid="ref5">5</xref>
). In conventional mitral valve replacement (MVR), the mitral valve is replaced with a prosthetic valve along with the chordae (    <xref ref-type="bibr" rid="ref6">6</xref>
–    <xref ref-type="bibr" rid="ref8">8</xref>
). However, it is known that cutting the subvalvular tissues negatively affects the function of the left ventricle and causes segmental wall motion defects (    <xref ref-type="bibr" rid="ref9">9</xref>
,    <xref ref-type="bibr" rid="ref10">10</xref>
). Preservation of the subvalvular structure (due to the functional apparatus of the mitral valve consisting of the chordae and papillary muscles) positively contributes to left ventricular function in the post-replacement period (    <xref ref-type="bibr" rid="ref11">11</xref>
). Our study aims to determine the effects of the surgical techniques of preserving leaflets and chordae on left ventricular function in patients undergoing MVR surgery.</p>
  </sec>
  <sec id="sec-2">
   <title>Materials and Methods</title>
  </sec>
  <sec id="sec-3">
   <title>Ethical Statement</title>
   <p id="b-2">This study was approved by the Medical Ethics Committee of the Faculty of Medicine at Gaziantep University on June 15    <sup>th</sup>
, 2009, with reference number 06-2009/239.</p>
  </sec>
  <sec id="sec-4">
   <title>Study Design</title>
   <p id="b-3">The study consisted of patients who underwent surgery in our clinic and was planned as a retrospective study. Patient data were collected from our clinic's web-based database, while control data were obtained from outpatient controls. From May 2002 to June 2010, 634 patients underwent MVR and/or other cardiac procedures (tricuspid valve repair, tricuspid valve replacement, aortic valve replacement, thrombectomy, SIRFA, and coronary surgery) at the Department of Cardiac and Vascular Surgery at Gaziantep University. On these cases, 358 (56.5%) underwent conventional MVR, 121 (19.1%) underwent Total leaflet protection + MVR, and 155 (24.4%) underwent Posterior leaflet protection + MVR. Based on this feature, patients were grouped into Conventional MVR (Group 1), Total leaflet-protected MVR (Group 2), and Posterior leaflet-protected MVR (Group 3). The groups were compared with statistical analyses for medium and long-term results. We analyzed all degrees of left ventricular end-diastolic diameter (LVDSC), left ventricular end-systolic diameter (LVSSC), end-diastolic volume (EDV), end-systolic volume (ESV) and ejection fraction (EF).</p>
   <sec id="sec-5">
    <title>Surgical Technique</title>
    <p id="b-4">A membrane oxygenator was used in patients undergoing standard median sternotomy. After cardiac arrest, the left atrium was reached through a classic left atriotomy. The leaflets and cords were carefully examined in patients who were planned for valve replacement after mitral valve control. All the valves and subvalve apparatus that could be protected were left in place, and the valves were dissected. In cases where protection was impossible, the mitral valve and instrument were examined entirely, single-plicated sutures were placed, and valve replacement was performed. In cases where the anterior and/or posterior leaflets and cords could be protected, plicated and sutures were placed one by one, passing through the annulus and leaflets, and the valve replacement was performed so that the valve movements did not affect the cords and leaflets.</p>
   </sec>
   <sec id="sec-6">
    <title>Statistical Method</title>
    <p id="b-5">NCSS (Number Cruncher Statistical System) 2007 &amp; PASS (Power Analysis and Sample Size) 2008 Statistical Software (Utah, USA) were used for statistical analysis. In evaluating the study data, in addition to descriptive statistics (mean, standard deviation, ratio, frequency), the Oneway ANOVA was used for comparing normal distribution parameters between groups, Tukey HDS test was used to identify the group causing the difference, and Paired sample t-test was used for intra-group comparisons. Qualitative data were evaluated using the chi-square test. A p-value&lt;0.05 was considered significant.</p>
   </sec>
  </sec>
  <sec id="sec-7">
   <title>Results</title>
   <p id="b-6">A total of 634 patients who underwent MVR were included in the study. 212 (33.4%) were male, and 422 (66.6%) were female, with an average age of 45.6±14.6 years (12-82). The average follow-up was 35.98±16.8 months, at this month was 86.1%, with a standard error of 4.7%. In the conventional surgery group, 346 out of 358 patients were alive (96.6%), and 12 deaths were observed, with an average survival time of 64.85±0.6 months. The last death was observed at 63 months, and the cumulative survival rate at this month was 88.4%, with a standard error of 3.9%.</p>
   <table-wrap id="tbl-1" position="float">
    <label>Table 1</label>
    <caption>
     <title>Upon analyzing the demographic data, concurrent comorbid factors such as CAD were more prevalent in Group-3 (p=0.01). In the total 634 surgeries, 615 patients were alive (97%), and 19 died. The average survival time was 65.18±0.4 months. The last death was observed at 65 months, and the cumulative survival rate</title>
    </caption>
    <graphic xlink:href="tbl-1-2.png">
     <alt-text>Table 1: Upon analyzing the demographic data, concurrent comorbid factors such as CAD were more prevalent in Group-3 (p=0.01). In the total 634 surgeries, 615 patients were alive (97%), and 19 died. The average survival time was 65.18±0.4 months. The last death was observed at 65 months, and the cum</alt-text>
    </graphic>
   </table-wrap>
   <p id="b-7">When evaluating the atrial fibrillation, left atrial thrombus, rhythm surgery, and left atrial thrombectomy among the groups, atrial fibrillation was more frequently associated with Group-1 (p=0.011). Similarly, rhythm surgery as a related surgical procedure was more regularly present in the same group (p=0.011). The occurrence rate of the left atrial thrombus and left atrial thrombectomy was higher in Group-2 (p=0.025 and p=0.040). 87.1% (n=552) of the patients did not have complications, while 12.9% (n=82) had complications. The post-ventricular rupture was seen in 0.2% (    <xref ref-type="bibr" rid="ref1">1</xref>
), bleeding in 3.9% (25), infection in 2.7% (    <xref ref-type="bibr" rid="ref17">17</xref>
), stroke in 0.5% (    <xref ref-type="bibr" rid="ref3">3</xref>
), valve degeneration in 1.1% (    <xref ref-type="bibr" rid="ref7">7</xref>
), struck valve in 1.9% (    <xref ref-type="bibr" rid="ref12">12</xref>
), and 7 in 2.7% (    <xref ref-type="bibr" rid="ref17">17</xref>
). The pre-operative EDV in the conventional surgery group was higher than those in the total leaflet protection and posterior leaflet protection groups (p=0.001 &amp; p=0.001). A decrease in postoperative EDV was observed at 11.07±5.24 in the total leaflet protection group compared to preoperative EDV (p&lt;0.01). A decrease in postoperative EDV was observed at 8.41±2.51 in the posterior leaflet protection group compared to preoperative EDV levels (p&lt;0.01). The levels of preoperative ESV in the conventional surgical group were higher than those in the total leaflet protection group (p=0.01). The levels of postoperative ESV were higher in the total leaflet protection and posterior leaflet protection(p=0.001 &amp; p=0.001). A decrease of 8.04±3.67 was observed in the postoperative ESV compared to the pre-operative ESV (p&lt;0.01). In the total leaflet protection group, a decrease of 11.72±5.76 was observed in the postoperative ESV compared to the preoperative ESV (p&lt;0.01). In posterior leaflet protection, a decrease of 12.4±4.91 was observed in the postoperative ESV compared to the preop ESV (p&lt;0.01).</p>
   <table-wrap id="tbl-2" position="float">
    <label>Table 2</label>
    <caption>
     <title>Pre-op ECHO Findings by Operation Types</title>
    </caption>
    <graphic xlink:href="tbl-2.png">
     <alt-text>Table 2: Pre-op ECHO Findings by Operation Types</alt-text>
    </graphic>
   </table-wrap>
   <table-wrap id="tbl-3" position="float">
    <label>Table 3</label>
    <caption>
     <title>Post op ECO Findings by Operation Types</title>
    </caption>
    <graphic xlink:href="tbl-3.png">
     <alt-text>Table 3: Post op ECO Findings by Operation Types</alt-text>
    </graphic>
   </table-wrap>
   <p id="b-8">The preoperative LVDSC in the posterior leaflet protection group were higher than those in the conventional surgery (p=0.044). In conventional surgery, postoperative LVDSC in the posterior leaflet protection group was higher than in the total leaflet protection (p=0.001 &amp; p=0.001). In the conventional surgical group, a decrease of 4.56±2.82 was observed in postoperative LVDSC compared to the preoperative LVDSC (p&lt;0.01). In the total leaflet protection, a significant decrease of 8.22±2.81 was observed in the postoperative LVDSC compared to the preoperative LVDSC (p&lt;0.01). In the posterior leaflet protection group, a decrease of 6.45±1.91 was observed in the postoperative LVDSC compared to the preoperative LVDSC (p&lt;0.01).</p>
   <p id="b-9">The postoperative LVSSC in the conventional surgical group was higher than those in the total leaflet protection and posterior leaflet protection groups (p=0.001 &amp; p=0.001). In the conventional surgical group, a decrease of 3.91±3.03 was observed in the postoperative LVSSC compared to the preoperative LVSSC (p&lt;0.01). In the total leaflet protection group, a decrease of 7.24±3.09 was observed in the postoperative LVSSC compared to the pre-operative LVSSC (p&lt;0.01). In the posterior leaflet protection, a decrease of 5.58±1.85 was observed in the postoperative LVSSC compared to the preoperative LVSSC (p&lt;0.01). The preoperative EF in the conventional surgical group were higher than those in the total leaflet protection and posterior leaflet protection (p=0.001&amp; p=0.004). Postoperative EF in the conventional surgical group was lower than in the total leaflet and posterior leaflet protections (p=0.001 &amp; p=0.001). In the conventional surgical group, an increase of 3.31±3.85 was observed in the postoperative EF compared to the preoperative EF (p&lt;0.01). In the total leaflet protection, an increase of 11.17±3.73 in post-operative EF was observed compared to pre-operative EF (p&lt;0.01). In the posterior leaflet protection group, an increase of 9.23±3.42 in post-operative EF was observed compared to pre-operative EF (p&lt;0.01).</p>
   <p id="b-10">In the total leaflet protection group, 119 out of 121 patients lived (98.3%), 2 were dead, and the average survival time was 64.62±0.53 months. The latest death was observed in the 65th month, and the cumulative survival rate at this month was 73.6, with a standard error of 21.3%. In the posterior leaflet protection group, 150 out of 155 patients lived (96.8%), five deaths were observed, and the average survival time was 64.72±0.99 months. The latest death was observed in the 61st month, and the cumulative survival rate at this month was 82, with a standard error of 11.3%. When the Log Rank test evaluated survival rates according to the operations, no differences were found in the 6- year survival rates (p:0.417). The highest survival was seen where total leaflet protection was performed. The mortality risk for males is 3.557 times higher than for females (OR:3,55; 95% CI: 1,739-9,173). The mortality risk for patients undergoing conventional surgical operations was 4.257 times higher (OR:4,25; 95%CI: 1,228- 14,761). The mortality risk was 3.075 times higher in infections (OR:3,07; 95%CI:1,07-8,821).</p>
  </sec>
  <sec id="sec-8">
   <title>Discussion</title>
   <p id="b-11">In the present study, total leaflet preservation posterior ventricular rupture is a fatal complication that can occur after MVR, which is prevented by preserving the posterior leaflet and maintaining continuity between the mitral annulus and papillary muscle (    <xref ref-type="bibr" rid="ref14">14</xref>
). Later, the method was reported to affect left ventricular ejection fraction positively. The increase in postoperative left ventricular wall stress was the reason for left ventricular dysfunction after MVR with the removal of the entire natural valve structure (    <xref ref-type="bibr" rid="ref15">15</xref>
). Our study found that the age was higher in the group that underwent conventional surgery, and the prevalence of CAD was higher in the group that underwent posterior leaflet-protected surgery.</p>
   <p id="b-12">The main goal of heart valve surgery is to preserve the natural heart valve as much as possible (    <xref ref-type="bibr" rid="ref16">16</xref>
). A study by Gürbüz et al. showed and, less frequently, posterior leaflet no effect on mortality and morbidity from mechanical valve types. Studies conducted by preservation methods in patients who underwent MVR surgery had positive effects on the clinical status of the patients and on left ventricular functions in echocardiographic measurements. Application of left ventricular preservation methods in patients planned for mitral valve surgery leads to significant improvement in left ventricular diameters and ejection fraction rates in medium and long-term follow-up. Preservation methods seriously affect left ventricular functions, especially preservation of chordae and apparatus will have positive effects on left ventricular functions. The protection of appliances that provide all atrioventricular integrity will overlap with cardiac functional integrity and will positively affect the output of the heart.</p>
   <p id="b-13">Since the first successful MVR, over three million individuals have undergone prosthetic valve replacement (    <xref ref-type="bibr" rid="ref12">12</xref>
). When performed with appropriate indications, valve replacement can reduce symptoms and improve quality of life while significantly extending life expectancy. However, like any surgery, valve replacement also risks adverse complications (    <xref ref-type="bibr" rid="ref13">13</xref>
). Mainly, different groups showed that results with mechanical valve-assisted MVR were similar, but complications were most common in conventional MVR (    <xref ref-type="bibr" rid="ref17">17</xref>
). The most commonly reported valve-related complication in the literature includes thromboembolism, valve thrombosis, and bleeding due to oral anti-coagulation. According to Debatez, the most common complications in patients undergoing conventional MVR are hemorrhage and thromboembolism (    <xref ref-type="bibr" rid="ref18">18</xref>
). In our study, one patient with posterior ventricular rupture underwent conventional MVR surgery, 76% of those who underwent a revision for bleeding complications had conventional MVR, 66.7% of those with valve hemolysis complications had conventional MVR surgery, and 66.7% of those with stroke complications had conventional MVR surgery. Before conventional MVR, the LVSSC was 43±4.8 and decreased to 39.1 ±5.4 after the operation. In the total leaflet-protected MVR, the LVSSC was 43.7±5.1 before the operation and decreased to 36.4±5.8 after the operation. In the posterior leaflet-protected MVR surgery, the LVSSC was 42.1±5.1 before the operation and decreased to 36.8±5.5 after the operation. Before conventional MVR, the EF was 52.5±7.6. This value increased to 55.8±7.8 after operation. In total leaflet-protected MVR, the EF was 49.8±5.3 before and increased to 60.9±6.4 after the operation. In the posterior leaflet-protected MVR, EF was 50.4±5.1 before operation and increased to 59.6±5.7 after the operation. Our results are similar to Debattista et al. Protection techniques positively affect left ventricular remodeling &amp; systolic function (    <xref ref-type="bibr" rid="ref19">19</xref>
). Operative mortality is significantly affected by patients' preoperative characteristics rather than valve performance. In a study by Mavitas et al., the operative mortality rate was 4.7%. Kratz et al. (    <xref ref-type="bibr" rid="ref18">18</xref>
) found 3.5%, Arom et al. (    <xref ref-type="bibr" rid="ref19">19</xref>
) found 9.9%, and Czer et al. (    <xref ref-type="bibr" rid="ref20">20</xref>
) found 11.9%. Our study found an operative mortality rate of 2.99%. David et al. (    <xref ref-type="bibr" rid="ref21">21</xref>
) reported a difference in favor of the group in which the mitral valve was protected compared to the group in which a classic MKR. Miki et al. (    <xref ref-type="bibr" rid="ref22">22</xref>
) obtained results similar to ours by reporting that there was no change in the preoperative and postoperative left ventricular EF in the group undergoing classic MVR, while there was an increase in the group undergoing protection. Yutaka et al. (    <xref ref-type="bibr" rid="ref23">23</xref>
) also reported in their radionuclide study on patients with mitral insufficiency that the left ventricular EF was better in the group undergoing protection compared to the group undergoing classic MKR.</p>
  </sec>
  <sec id="sec-9">
   <title>Conclusion</title>
   <p id="b-14">Left ventricular protection methods in patients planned for MVR surgery significantly improve left ventricular diameters and ejection fraction rates in mid &amp; long-term follow-up. We believe that protection methods positively impact left ventricular function, especially the preservation of cordae and apparatus, which positively affects left ventricular function. Preservation of all apparatus that ensure atrioventricular integrity positively influences cardiac functional integrity, positively affecting the heart's output. In this regard, we think preserving all structures that can be preserved or preserving posterior leaflets and cordae in case it cannot be done will be beneficial in increasing EF.</p>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="ref1">
    <label>1</label>
    <mixed-citation publication-type="journal">Saia F, Loforte A, Pacini D. Innovative transcatheter procedures for the treatment of heart failure. Cardiovasc Diagn Ther. 2021;11(1):292-300</mixed-citation>
   </ref>
   <ref id="ref2">
    <label>2</label>
    <mixed-citation publication-type="journal">Hinohara TT, Reardon MJ, Goel SS. Latest Advances in Transcatheter Mitral Valve Replacement. Heart Int. 2021;15(2):79-83</mixed-citation>
   </ref>
   <ref id="ref3">
    <label>3</label>
    <mixed-citation publication-type="journal">Yu J, Qiao E, Wang W. Mechanical or biologic prostheses for mitral valve replacement: A systematic review and meta-analysis. Clin Cardiol. 2022;45(7):701-16</mixed-citation>
   </ref>
   <ref id="ref4">
    <label>4</label>
    <mixed-citation publication-type="journal">Cammalleri V, Mega S, Ussia GP, Grigioni F. Mitral and Tricuspid Valves Percutaneous Repair in Patients with Advanced Heart Failure: Panacea, or Pandora's Box? Heart Fail Clin. 2021;17(4):607-18</mixed-citation>
   </ref>
   <ref id="ref5">
    <label>5</label>
    <mixed-citation publication-type="journal">Cavalcanti LRP, Sá M, Perazzo Á M, Escorel Neto AC, Gomes RAF, Weymann A, et al. Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications. Curr Atheroscler Rep. 2020; 22(2):9</mixed-citation>
   </ref>
   <ref id="ref6">
    <label>6</label>
    <mixed-citation publication-type="journal">Joseph KM, Nyman C. Mitral Valve Annuloplasty Failure and Percutaneous Treatment Options. Curr Cardiol Rep. 2021;23(10):140</mixed-citation>
   </ref>
   <ref id="ref7">
    <label>7</label>
    <mixed-citation publication-type="journal">Harky A, Botezatu B, Kakar S, Ren M, Shirke MM, Pullan M. Mitral valve diseases: Pathophysiology and interventions. Prog Cardiovasc Dis. 2021;67:98-104</mixed-citation>
   </ref>
   <ref id="ref8">
    <label>8</label>
    <mixed-citation publication-type="journal">Churchill TW, Yucel E, Deferm S, Levine RA, Hung J, Bertrand PB. Mitral Valve Dysfunction in Patients With Annular Calcification: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;80(7):739-51</mixed-citation>
   </ref>
   <ref id="ref9">
    <label>9</label>
    <mixed-citation publication-type="journal">Di Mauro M, Cargoni M, Liberi R, Lorusso R, Calafiore AM. Mitral valve repair or replacement. How long is this feud to last? J Card Surg. 2022;37(6):1599-601</mixed-citation>
   </ref>
   <ref id="ref10">
    <label>10</label>
    <mixed-citation publication-type="journal">Fattouch K, Calafiore AM. Mitral valve repair: Regulatory or ethical problem? J Card Surg. 2022;37(12):4094-6</mixed-citation>
   </ref>
   <ref id="ref11">
    <label>11</label>
    <mixed-citation publication-type="journal">Hsieh WC, Aboud A, Henry BM, Kan CD, Omara M, Lindner J, et al. Mitral Valve Replacement Using Subvalvular Apparatus: A Systematic Review and Meta-Analysis. Heart Surg Forum. 2020;23(3):E385- e92</mixed-citation>
   </ref>
   <ref id="ref12">
    <label>12</label>
    <mixed-citation publication-type="journal">Koziarz A, Makhdoum A, Butany J, Ouzounian M, Chung J. Modes of bioprosthetic valve failure: a narrative review. Curr Opin Cardiol. 2020;35(2):123-32</mixed-citation>
   </ref>
   <ref id="ref13">
    <label>13</label>
    <mixed-citation publication-type="journal">Paparella D, Squiccimarro E, Di Mauro M, Katsavrias K, Calafiore AM. Acute iatrogenic complications after mitral valve repair. J Card Surg. 2022;37(12):4088-93</mixed-citation>
   </ref>
   <ref id="ref14">
    <label>14</label>
    <mixed-citation publication-type="journal">You T, Wang W, Yi K, Gao J, Zhang X, He SE, et al. Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis. J Cardiothorac Surg. 2021;16(1):293 41 77 Cord Protection Methods Arslanoğlu et al.</mixed-citation>
   </ref>
   <ref id="ref15">
    <label>15</label>
    <mixed-citation publication-type="journal">Lundell DC, Laks H, Geha AS, Khachane VB, Hammond GL. The Importance of Myocardial Protection in Combined Aortic Valve Replacement and Myocardial Revascularization. The Annals of Thoracic Surgery. 1979;28(6):501-8</mixed-citation>
   </ref>
   <ref id="ref16">
    <label>16</label>
    <mixed-citation publication-type="journal">Jegaden O, Eker A, Delahaye F, Montagna P, Ossette J, De Gevigney GD, et al. Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve. The Annals of Thoracic Surgery. 1994;58(6):1721-7</mixed-citation>
   </ref>
   <ref id="ref17">
    <label>17</label>
    <mixed-citation publication-type="journal">Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation. 1984;69(2):223-32</mixed-citation>
   </ref>
   <ref id="ref18">
    <label>18</label>
    <mixed-citation publication-type="journal">Kratz JM, Crawford FA, Sade RM, Crumbley AJ, Stroud MR. St. Jude prosthesis for aortic and mitral valve replacement: A ten-year experience. The Annals of Thoracic Surgery. 1993;56(3):462-8</mixed-citation>
   </ref>
   <ref id="ref19">
    <label>19</label>
    <mixed-citation publication-type="journal">Arom KV, Nicoloff DM, Kersten TE, Northrup WF, Lindsay WG, Emery RW. Ten years' experience with the St. Jude Medical valve prosthesis. The Annals of Thoracic Surgery. 1989;47(6):831-7</mixed-citation>
   </ref>
   <ref id="ref20">
    <label>20</label>
    <mixed-citation publication-type="journal">Czer LSC, Chaux A, Matloff JM, DeRobertis MA, Nessim SA, Scarlata D, et al. Ten-year experience with the St. Jude Medical valve for primary valve replacement. The Journal of Thoracic and Cardiovascular Surgery. 1990;100(1):44-55</mixed-citation>
   </ref>
   <ref id="ref21">
    <label>21</label>
    <mixed-citation publication-type="journal">David TE, Burns RJ, Maria Bacchus C, Druck MN, Weisel RD. Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae. The Journal of Thoracic and Cardiovascular Surgery. 1984;88(5):718-25</mixed-citation>
   </ref>
   <ref id="ref22">
    <label>22</label>
    <mixed-citation publication-type="journal">Miki S, Kusuhara K, Ueda Y, Komeda M, Ohkita Y, Tahata T. Mitral Valve Replacement with Preservation of Chordae Tendineae and Papillary Muscles. The Annals of Thoracic Surgery. 1988;45(1):28-34</mixed-citation>
   </ref>
   <ref id="ref23">
    <label>23</label>
    <mixed-citation publication-type="journal">Okita Y, Miki S, Kusuhara K, Ueda Y, Tahata T, Yamanaka K, et al. Analysis of left ventricular motion after mitral valve replacement with a technique of preservation of all chordae tendineae. The Journal of Thoracic and Cardiovascular Surgery. 1992;104(3):786-95</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
